Schroder Investment Management Group Bio N Tech Se Transaction History

Schroder Investment Management Group

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$205.93 - $447.23 $57.4 Million - $125 Million	-278,584 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$113.32 - $241.49 $24.5 Million - $52.3 Million	216,371 Added 347.79%	278,584 $62.4 Million
Q1 2021 May 17, 2021	BUY	$85.73 - $119.5 $394,872 - $550,417	4,606 Added 8.0%	62,213 $6.79 Million
Q4 2020 Feb 16, 2021	BUY	$72.71 - $129.54 $1.26 Million - $2.24 Million	17,262 Added 42.79%	57,607 $4.7 Million
Q3 2020 Nov 13, 2020	SELL	$57.81 - $104.17 $350,791 - $632,103	-6,068 Reduced 13.07%	40,345 $2.97 Million
Q2 2020 Aug 13, 2020	SELL	$38.58 - $66.74 $395,869 - $684,819	-10,261 Reduced 18.11%	46,413 $3.1 Million
Q1 2020 May 15, 2020	SELL	$28.55 - $92.0 $1.03 Million - $3.32 Million	-36,122 Reduced 38.93%	56,674 $2.99 Million
Q4 2019 Feb 11, 2020	BUY	$12.75 - $36.91 $1.18 Million - $3.43 Million	92,796 New	92,796 $3.14 Million

357

38.5M

2.45M

2.29M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.7B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.